A double-blinded, randomized, split-side, vehicle-controlled study of the efficacy of cleanser containing Acanthus ebracteatus Vahl., Suregada multiflora, and Acacia concinna in patients with atopic dermatitis: A pilot study

被引:0
|
作者
Winayanuwattikun, Waranaree [1 ]
Varothai, Supenya [1 ]
Tuchinda, Papapit [1 ]
Kulthanan, Kanokvalai [1 ]
Prasertworonun, Nuntida [1 ]
Dasri, Phongphimon [2 ]
Wanichthanarak, Kwanjeera [2 ,3 ]
Akarasereenont, Pravit [2 ,3 ,4 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Dermatol, 2 Wanglang Rd, Bangkok 10700, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Ctr Appl Thai Tradit Med, Bangkok, Thailand
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Metabol & Phen Ctr, Bangkok, Thailand
[4] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pharmacol, Bangkok, Thailand
来源
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY | 2023年 / 41卷 / 04期
关键词
atopic dermatitis; cleanser; herbal medicine; transepidermal water loss; adjunctive therapy; SKIN BARRIER FUNCTION; STRATUM-CORNEUM; HEALTHY SKIN; THERAPY; WATER; TEWL;
D O I
10.12932/ap-050519-0554
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Barrier repair therapy is the key management approach for both eczematous and nonlesional skin of atopic dermatitis. The use of appropriate cleansers to enhance skin hydration is an adjunctive treatment that increases topical drug penetration. Anti-inflammatory properties of various medicinal plants in tropical Asia have been reported.Objective: Investigate the efficacy of herbal cleanser containing a combination of herbal extracts from Acanthus ebracteatus Vahl., Suregada multiflora, and Acacia concinna on seemingly intact skin in patients with atopic dermatitis by measuring improvements in the skin barrier function.Methods: This 2-week pilot study was a split-side, randomized, double-blinded, vehicle-controlled trial. All patients (n = 30) were asked to use both a cleanser with an active formulation containing the herbal extracts and a vehicle-controlled cleanser on each side of mid-volar forearm. Biophysical assessments including transepidermal water loss (TEWL), skin hydration, skin pH, and skin roughness were performed at baseline and upon study completion. Results: Compared to baseline, the median percentage change in TEWL at the end of the study was significantly greater for the active side 10.4 (-19, 20.7) g/m2h than the control side-13.2 (-28.7, 9.1) g/m2h; p = 0.01. The median percentage change of skin hydration, skin pH, and skin roughness of the active side compared to the control side had no a statistical significance.Conclusions: This cleanser is beneficial when used as adjunctive therapy. Further studies should evaluate its anti-sinflammatory properties in the remedy or active phase of atopic dermatitis or other inflammatory skin diseases.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 44 条
  • [21] Efficacy and safety of topical delgocitinib (JTE-052), janus kinase inhibitor, in Japanese pediatric patients with atopic dermatitis: A phase II, randomized, double-blind, vehicle-controlled study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB53 - AB53
  • [22] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 854 - 862
  • [23] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB52 - AB52
  • [24] Randomized, double-blinded, vehicle-controlled, split-face study to evaluate the effects of topical application of a Gold Silk Sericin/Niacinamide/Signaline complex on biophysical parameters related to skin ageing
    Berardesca, E.
    Ardigo, M.
    Cameli, N.
    Mariano, M.
    Agozzino, M.
    Matts, P. J.
    INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2015, 37 (06) : 606 - 612
  • [25] Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: Results from a randomized, double-blind, vehicle-controlled study
    Schachner, LA
    Lamerson, C
    Sheehan, MP
    Boguniewicz, M
    Mosser, J
    Raimer, S
    Shull, T
    Jaracz, E
    PEDIATRICS, 2005, 116 (03) : E334 - E342
  • [26] Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study
    Ahn, Jin Hyang
    Yun, Younghee
    Kim, Min Hee
    Ko, Seoung-Gyu
    Kim, Kyu Seok
    Choi, Inhwa
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 40 : 22 - 28
  • [27] Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
    Guttman-Yassky, Emma
    Silverberg, Jonathan I.
    Nemoto, Osamu
    Forman, Seth B.
    Wilke, August
    Prescilla, Randy
    de la Pena, Amparo
    Nunes, Fabio P.
    Janes, Jonathan
    Gamalo, Margaret
    Donley, David
    Paik, Jim
    DeLozier, Amy M.
    Nickoloff, Brian J.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 913 - +
  • [28] A randomized, double-blind, vehicle-controlled, multi-center study to evaluate the safety and efficacy of topically applied AN0128 1% cream for the treatment of mild to moderate atopic dermatitis
    Beutner, K.
    Bucko, A.
    Jones, T.
    Loss, R.
    Matheson, R.
    Jarratt, M.
    Fowler, J.
    Rich, P.
    Stough, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 97 - 97
  • [29] A randomized, double-blind, vehicle-controlled, multi-center study to evaluate the safety and efficacy of topically applied AN0128 cream, 1% for the treatment of mild to moderate atopic dermatitis
    Beutner, Karl
    Jones, Terry
    Bucko, Alicia
    Loss, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB72 - AB72
  • [30] Efficacy and safety of Ojeok-san in Korean female patients with cold hypersensitivity in the hands and feet: study protocol for a randomized, double-blinded, placebo-controlled, multicenter pilot study
    Youme Ko
    Ho-Yeon Go
    In-Sik Han
    Kyou-Young Lee
    Tae-Hoon Kim
    Jin-Moo Lee
    Jun-Bok Jang
    Yun-Kyung Song
    Seung-Ho Sun
    Chan-Yong Jeon
    Seong-Gyu Ko
    Trials, 19